Approval · Notice of Compliance 36826 · 2026
MEGESTROL: Notice of Compliance 36826
Issued February 2, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36826
- Date
- February 2, 2026
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEGESTROL | Not yet assigned | — |
Medicinal ingredients
- MEGESTROL ACETATE 40 MG per TAB
- MEGESTROL ACETATE 160 MG per TAB